Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

NewsGuard 100/100 Score

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced it is in the final developmental stages of a pen-diagnostic test with the University of Liverpool, which will allow farmers and vets to diagnose livestock exposure to fluke on-farm, with results available within 10 minutes.

Prevalent in over 70 countries worldwide and a common parasite affecting cattle and sheep in the UK, Fasciola hepatica (the liver fluke) is estimated to cause over the US 3.2 billion dollars in livestock production losses.

Current liver fluke diagnostic tests require laboratory analysis, with a typical wait time of a week or more for results. Together with the impracticalities of regathering livestock, many tend to treat without a diagnosis, contributing to the development of resistance to flukicide drugs. Developed in collaboration with Mologic, the Liverpool test detects antibodies circulating in the blood of fluke-infected animals through a blood droplet taken from the ear.

Results are available within 10 minutes to allow farmers to make an informed diagnosis and treat at the point of need, providing an innovative solution in liver fluke disease management. Early fluke detection will prevent acute disease in sheep and for beef farmers, the ability to monitor infection at housing. Most importantly, it will allow the implementation of targeted treatment programs, all of which will aid in slowing the development of flukicide resistance.

To gain further industry insight into how a pen-side diagnostic test for liver fluke should function, the University of Liverpool and Mologic has launched a short market research survey. They are looking for views from all aspects of the farming industry and urge anyone to take part.

The survey should take approximately 10-15 minutes to complete and is available from the 7th December 2020 to 10th January 2021. Industry feedback will drive the final test format. A link to the survey can be found here: https://liverpool.onlinesurveys.ac.uk/market-research-survey-for-liver-fluke 

Professor Diana Williams and Tessa Walsh Ph.D., Infection Biology at the University of Liverpool jointly commented: “We are delighted that what started as a research tool is now being developed as a practical diagnostic test for farmers and vets, to support strategic control for this common, devastating disease. The project has been supported by AHDB and BBSRC to bring it to a point where we can start to develop the test commercially.”

In fluke endemic areas, industry practice is often to treat in the absence of any diagnosis. As seen with antibiotics, an overreliance on flukicides gives rise to anthelmintic resistance and poses a significant threat and constraint to livestock production. Farm testing offers the industry a cost-effective route to early diagnosis and an on-the-spot targeted treatment. A positive outcome for the animal, the producer, the processor and the consumer.”

Dr. Alison Wakeham, Project Leader, Mologic

Lesley Stubbings representing the Sustainable Control of Parasites (SCOPS) group added: “Testing is a key element in Liver Fluke control and the SCOPS group are excited by the potential for a test that can be used 'pen-side' on farm. This would enable farmers to treat only when necessary, ensuring timely treatment while avoiding over-use of flukicides, which is critical if we are to preserve the efficacy of the medicines available to us.”

It is great to see that research is being put into practice. This tool is an exciting development that will provide rapid results allowing farmers to make more informed decisions as to whether an animal needs treated for liver fluke or not.”

Rebecca Small, Control of Worms Sustainably (COWS)

To find out more about Mologic, please visit: https://mologic.co.uk/

To find out more about the Company’s lateral flow technology for agriculture and the environment, please visit: https://www.agrialert.co.uk/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Survey unveils India's rising tide of metabolic diseases